文献综述

肺炎支原体下呼吸道感染的发病机制及糖皮质激素的治疗作用

  • 蔡金龙 ,
  • 曲书强
展开
  • 哈尔滨医科大学附属第二医院( 黑龙江哈尔滨 150001)

收稿日期: 2015-06-15

  网络出版日期: 2015-06-15

The pathogenesis of the lower respiratory infection by Mycoplasma pneumoniae and the therapeutic effects of glucocorticoid

  • CAI Jinlong ,
  • QU Shuqiang
Expand
  • The Second Affiliated Hospital of Harbin Medical Unisersity, Haerbin 150001, Heilongjiang, China

Received date: 2015-06-15

  Online published: 2015-06-15

摘要

 肺炎支原体是引起儿童社区获得性肺炎的常见病原体之一。近年来肺炎支原体下呼吸道感染的发病率呈增加的趋势,并且重症、难治性肺炎支原体肺炎的报道也越来越多。糖皮质激素具有抗炎、抗过敏及抑制免疫反应等药理作用,是目前最有效的抗炎药物。文章就肺炎支原体下呼吸道感染的发病机制及糖皮质激素的治疗作用进行综述。

本文引用格式

蔡金龙 , 曲书强 . 肺炎支原体下呼吸道感染的发病机制及糖皮质激素的治疗作用[J]. 临床儿科杂志, 2015 , 33(6) : 597 . DOI: 10.3969 j.issn.1000-3606.2015.06.024

Abstract

Mycoplasma pneumonia (MP) is one of common pathogens of community-acquired pneumonia in children. In recent years, the incidence of MP pneumonia (MPP) shows a trend of increasing. The report of severe refractory MPP was more and more. Glucocorticoids has anti-inflammatory, anti-allergic and restraining immune response pharmacological effects and is the most effective anti-inflammatory drug currently. In this paper, pathogenesis of the lower respiratory infection by MP and the therapeutic effects of glucocorticoid were reviewed.
文章导航

/